HCID 178497113, compound → HCID 178524092, compound
Reaction equation
C[O:2][C:3]([C:5]1[CH:6]=[CH:7][C:8]2[CH2:9][C@H:10]3[C@@H:15]([C:16]=2[CH:17]=1)[CH2:14][CH2:13][CH2:12][N:11]3[C:18]([C:20]1[CH:28]=[CH:27][C:23]2[NH:24][CH:25]=[N:26][C:22]=2[CH:21]=1)=[O:19])=[O:4].COC(C1C=CC2[C@@H]3[C@@H](N(C(C4C=CC5NC=NC=5C=4)=O)CCC3)CC=2C=1)=O>>[NH:24]1[C:23]2[CH:27]=[CH:28][C:20]([C:18]([N:11]3[CH2:12][CH2:13][CH2:14][C@@H:9]4[C:8]5[CH:7]=[CH:6][C:5]([C:3]([OH:2])=[O:4])=[CH:17][C:16]=5[CH2:15][C@H:10]34)=[O:19])=[CH:21][C:22]=2[N:26]=[CH:25]1Participants
3
Procedure
The title compound is prepared from a ca. 1:1 mixture of cis-1-(1H-benzoimidazole-5-carbonyl)-2,3,4,4a,9,9a-hexahydro-1H-indeno[2,1-b]pyridine-6-carboxylic acid methyl ester and cis-1-(1H-benzoimidazole-5-carbonyl)-2,3,4,4a,9,9a-hexahydro-1H-indeno[2,1-b]pyridine-7-carboxylic acid methyl ester following a procedure analogous to that described in Example 35 and separated from Example 98 by HPLC on reversed phase (MeCN/H2O). Yield: 5% of theory; Mass spectrum (ESI+): m/z=362 [M+H]+.
Workup
- customseparated from Example 98 by HPLC on reversed phase (MeCN/H2O)
Sources & evidence
- ORD record
- ord-80eb913b3e174ef98fbb22f5e82c7e97
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120769B2
Reaction notes
Loading…